| Name | Evifacotrep |
|---|
| Description | Evifacotrep, a short transient receptor potential channel 5 (TRPC5) antagonist (WO2020061162, compound 100), can be used for the research of neurological diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
TRPC5[1] |
| In Vitro | Evifacotrep is a short transient receptor potential channel 5 (TRPC5) antagonist[1]. |
| References |
[1]. WO2020061162 |
| Molecular Formula | C18H12ClF4N5O2 |
|---|---|
| Molecular Weight | 441.77 |